logo
Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference

Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference

Cision Canada20-06-2025
, June 20, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces that the recently published narrative review titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review" (DOI: https://doi.org/10.7759/cureus.81577) has been officially accepted for presentation at PAINWEEK 2025, the national conference on pain management, taking place this September in Las Vegas, Nevada.
PAINWEEK is a prestigious event that brings together leading clinicians, researchers, and educators in the field of pain medicine, offering a unique platform to showcase innovative research and best practices. The narrative review, selected through a competitive peer-review process, provides important insights into the potential of synthetic cannabidiol (CBD), administered through extended-release formulations, as a well-tolerated, non-opioid analgesic alternative.
Innocan is developing LPT-CBD, an innovative injectable liposomal drug product designed for the sustained release of synthetic CBD. Supported by multiple animal studies, LPT-CBD has demonstrated steady plasma CBD levels for up to four weeks, prolonged pain relief, and excellent tolerability—offering a promising alternative to current opioid medications and addressing the urgent need to reduce opioid dependency.
LPT-CBD will be showcased at the PAINWEEK conference to thousands of healthcare professionals and potential pharmaceutical partners, positioning it at the forefront of groundbreaking non-opioid chronic pain management solutions.
"We are honored to be included among the esteemed voices presenting at PAINWEEK this year," said Iris Bincovich, Chief Executive Officer of Innocan."This recognition underscores our commitment to advancing evidence-based pain care and contributing meaningful research to the field."
About Innocan:
Innocan is an innovator in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan carries on business through its 60% owned subsidiary, BI Sky Global Ltd., which focuses on advanced, targeted online sales.
Contact Information:
For Innocan Pharma Corporation:
Iris Bincovich, CEO
+1 5162104025
+972-54-3012842
+442037699377
[email protected]
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Caution Regarding Forward-Looking Information
Certain information set forth in this news release, including, without limitation, the Company's plans for human trials of its LPT-CBD platform, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan's control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of production and distribution arrangements.
Forward-looking information is subject to various risks and uncertainties that could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: global and local (national) economic, political, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and potential disruption of relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import/export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner). The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release. A comprehensive discussion of other risks that impact Innocan can be found in Innocan's public reports and filings which are available under Innocan's profile at www.sedarplus.ca.
Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

WSIB and OCEU reach tentative agreement to end labour disruption Français
WSIB and OCEU reach tentative agreement to end labour disruption Français

Cision Canada

time18 hours ago

  • Cision Canada

WSIB and OCEU reach tentative agreement to end labour disruption Français

TORONTO, July 5, 2025 /CNW/ - The Workplace Safety and Insurance Board (WSIB) is pleased to announce a tentative agreement has been reached with the Ontario Compensation Employees Union (OCEU). The organization looks forward to welcoming back its full team within 24 hours of a successful ratification vote. "Our number one priority has always been—and continues to be—helping the people who depend on us," said Jeff Lang, President and CEO of the WSIB. "We do work that makes a difference in people's lives and in our communities. I am proud of our team's work the last few weeks and am very excited for everyone to come back together so we can keep supporting Ontarians who need us." As normal service resumes, people can continue to log in to the WSIB's website anytime, 24/7 to: Report an injury or illness Submit documents for an existing claim See claim, payment, and health benefit information in real time Register a new business Access clearances "We thank Ontarians for the patience they've shown us during the labour disruption," said Lang. "Our team is committed to delivering better, easier, and faster service to Ontarians and we can't wait to get back to doing what we do best – helping people." The WSIB provides workplace injury and illness insurance to more than 5.3 million people in more than 300,000 workplaces across Ontario. When an injury or illness happens on the job, the WSIB provides wage-loss benefits, medical coverage and support to help people get back to work. Funded by Ontario businesses, the WSIB also provides no-fault collective liability insurance and access to industry-specific health and safety information.

Sheraton Vancouver Guildford workers prepare to strike
Sheraton Vancouver Guildford workers prepare to strike

Cision Canada

time20 hours ago

  • Cision Canada

Sheraton Vancouver Guildford workers prepare to strike

SURREY, BC, July 5, 2025 /CNW/ - Unifor Local 3000 members at the Sheraton Vancouver Guildford Hotel are preparing for strike action later today. "The employer has left us with no other choice," said Unifor Western Regional Director Gavin McGarrigle. "Our members are the heart of the hotel, and after more than a year without a fair agreement, they are prepared to strike to demand respect and fair wages." Unifor Local 3000 members voted to reject a tentative agreement with the company. The union will be in a legal strike position as of 12:45 p.m. Pacific on July 5, 2025. The bargaining unit includes 120 full-time and 24 part-time workers, who have been without a contract since April 2024. The Sheraton Vancouver Guildford is owned and operated by Pacific Reach Properties, a Vancouver-based investment firm with diverse holdings across real estate, hospitality, healthcare, and tech sectors. The company has sub-contracted human resources and collective bargaining responsibilities to Hospitality Industrial Relations (HIR), a Vancouver-based multi-employer group that negotiates on behalf of various hotel and tourism operators in British Columbia. "Wages at the Sheraton have failed to keep up with the rising cost of living in the Lower Mainland," said Adrian Burnett, President of Unifor Local 3000. "Our members are struggling to make ends meet while working for a hotel owned by a company with deep pockets. It's unacceptable." Unifor members voted overwhelmingly in favour of strike action if necessary, sending a strong message to the employer that a fair deal must be secured. The union remains committed to negotiating an agreement at the table but is prepared to take strike action should an agreement not be reached. Unifor is Canada's largest union in the private sector, representing 320,000 workers in every major area of the economy. The union advocates for all working people and their rights, fights for equality and social justice in Canada and abroad, and strives to create progressive change for a better future.

Lotto Max - A $65 million jackpot and an estimated 8 Maxmillions in the next draw Français
Lotto Max - A $65 million jackpot and an estimated 8 Maxmillions in the next draw Français

Cision Canada

timea day ago

  • Cision Canada

Lotto Max - A $65 million jackpot and an estimated 8 Maxmillions in the next draw Français

MONTRÉAL, July 5, 2025 /CNW/ - In the next Lotto Max draw, slated for Tuesday, July 8, the prize pool will be $73 million and include a $65 million jackpot and an estimated 8 Maxmillions. "A Lotto Max jackpot was just won in June. We're hoping that Lady Luck strikes again in Québec in Tuesday's draw, when the jackpot is $65 million," says Isabelle Jean, Executive Vice-President and Chief Operating Officer of Lottery Games at Loto-Québec. Lotto Max continues to churn out winners in Québec Lotto Max players in Québec have won over $3.925 billion since its launch in 2009. In total, there have been 46 jackpot wins in the province, including 3 of $70,000,000—the largest jackpots ever won in Québec—in the February 25 and October 9, 2020, and June 7, 2022, draws. One $65,000,000 jackpot, four $60,000,000 jackpots, five $55,000,000 jackpots, and nine $50,000,000 jackpots have also been won in Quebec. In addition to these jackpot wins, Lotto Max players in Québec have also won a total of 247 Maxmillions prizes, each worth $1 million, and 151 shares of Maxmillions prizes. Draw results are available online at About Loto-Québec Loto-Québec has been delivering entertainment to Quebecers for over 50 years, and its operations benefit Québec as a whole. Last year, the corporation paid out almost $1.8 billion in prizes to winners across Québec. Major prize winners are listed on the Winners page in the Lotteries section of Read their stories. The responsible commercialization of lottery and gaming products is central to Loto-Québec's operations. The corporation has been granted the highest internationally recognized certification in responsible gaming by the World Lottery Association.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store